Profile
Sector:
HealthcareCountry:
CanadaIPO:
Website:
http://www.fsdpharma.comNext earnings report:
14 May 2025Last dividends:
N/ANext dividends:
N/APrice
regular market | Tue, 19 Nov 2024 21:00:00 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
QNTM Latest News
Christian Attar Law Firm and Freedman Normand Friedland LLP, in conjunction with forensic investigators, have uncovered evidence of a potential multi-year market manipulation scheme that has caused substantial damages to the Company and its shareholders TORONTO, ON / ACCESSWIRE / October 21, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces the Company, on 20th October 2024, has filed a complaint in the United States District Court for the Southern District of New York alleging that CIBC World Markets (CIBC), RBC Dominion Securities (RBC), and others (the "Defendants") engaged in market manipulation schemes that violated Section 10(b) and Rule 10b-5(a) and (c) and Section 9(a) of the Securities Exchange Act of 1934.
What type of business is Quantum BioPharma?
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada.
What sector is Quantum BioPharma in?
Quantum BioPharma is in the Healthcare sector
What industry is Quantum BioPharma in?
Quantum BioPharma is in the Drug Manufacturers - Specialty & Generic industry
What country is Quantum BioPharma from?
Quantum BioPharma is headquartered in Canada
What is Quantum BioPharma website?
https://www.fsdpharma.com
Is Quantum BioPharma in the S&P 500?
No, Quantum BioPharma is not included in the S&P 500 index
Is Quantum BioPharma in the NASDAQ 100?
No, Quantum BioPharma is not included in the NASDAQ 100 index
Is Quantum BioPharma in the Dow Jones?
No, Quantum BioPharma is not included in the Dow Jones index
When was Quantum BioPharma the previous earnings report?
No data
When does Quantum BioPharma earnings report?
The next expected earnings date for Quantum BioPharma is 14 May 2025